Navigation Links
Helix BioPharma Corp. announces fiscal 2007 results
Date:10/26/2007

WKN: 918 846

AURORA, ON, Oct. 26 /PRNewswire-FirstCall/ - Helix BioPharma Corp. (TSX, FSE: "HBP") today announced financial results for the year ended July 31, 2007.

During the 2007 fiscal year, the Company continued to make progress with its clinical (Topical Interferon Alpha-2b) and pre-clinical (L-DOS47) development programs. The following are selected highlights during the 2007 fiscal year and subsequent to year-end.

HIGHLIGHTS

- Topical Interferon Alpha-2b

- Announced positive Phase II clinical results with Topical

Interferon Alpha-2b in patients with HPV-induced low-grade

squamous intraepithelial lesions ("LSIL")

- Initiated enrollment in Phase II clinical trial with Topical

Interferon Alpha-2b in patients with HPV-induced ano-genital warts

- L-DOS47

- Awarded two U.S. patents for DOS47, a broad anti-cancer

therapeutic candidate

- Presented L-DOS47 findings at the fourth international conference

on "Tumour Microenvironment" in Florence, Italy

- Presented L-DOS47 findings at Keystone Symposia meeting,

"Antibodies as Drugs: From Basic Biology to Clinic"

- Signed L-DOS47 manufacturing agreement with BioVectra DCL

- Financing

- Completed a private placement financing on October 11, 2006 for

gross proceeds of $7,044,500.

- Other

- Shareholders approved management proposals and elected

management's slate of directors at the 2007 annual meeting of

shareholders, following a proxy dispute

- Announced University of Arizona Professor, Kenneth D. Hatch,M.D.,

as medical advisor

- Mr. Jerome F. McElroy resigned as Chairman and Director of the

Company

- Introduced a new company logo as part of our ongoing efforts to<
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Metavante Corp. will continue M&A activity
2. Lucigen Corp. enters global licensing agreement
3. CIO Leadership Series: Jane Durment, Marcus Corp.
4. Brady Corp. acquires Korean counterpart
5. Brady Corp. raises $137 million in public offering
6. Symphony Corp. and CareEvolution to partner
7. RedPrairie Corp. introduces new supply chain software
8. California investors acquire RedPrairie Corp.
9. Symphony Corp. moving into Fitchburg Technology Campus
10. Local group building Dane County economic development corp.
11. M & Is Metavante completes Brasfield Corp. acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Currently offering a comprehensive ... D Weighing, Rice Lake, and Ohaus, Pipette.com has ... The Sartorius CPA Semi-Micro Balance is ideal for ... and user-friendly laboratory balance. , Sartorius is a ... laboratory balances are well known for their high ...
(Date:10/22/2014)... 22, 2014   Synthetic Biologics, Inc. (NYSE ... for serious infections and diseases, announced today that the ... of Allowance for a composition of matter patent application ... program, SYN-004. This is Synthetic Biologics, first allowed ... and adds to the Company,s extensive C. difficile ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 /PRNewswire/ ... announced today that rare disease expert John C. ... research. Dr. McKew brings more than two decades of ... the National Institutes of Health, Wyeth Research and Genetics ... will lead aTyr,s efforts to expand and translate its ...
(Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
Breaking Biology Technology:Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... Calif., March 31 Watson Pharmaceuticals, Inc. (NYSE: ... today that the United States District Court for the ... of Concerta (methylphenidate hydrochloride extended-release tablets) does not infringe ... that the ,373 Patent is invalid. The opinion, ...
... One of the nation,s leading independent research institutes ... align to support the critical mission of protecting the ... solutions. , , Officials at ... expanding MRI,s existing operations by establishing a wholly owned ...
... process platform intended to meet the needs of the Obama ... ... Aliso Viejo, California (PRWEB) March 29, 2009 -- Applied Technology ... BodySensor™ and BodyBalance™ system from its new Digital Data ...
Cached Biology Technology:Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 2Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 3Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors 4Company to Provide Technology Platform for Digital Data Collection of Computerized Patient Records 2
(Date:10/15/2014)... is spreading rapidly and to an unexpected extent. The ... past and the virus shows a new disease dynamic ... For this reason, the German National Academy of Sciences ... Engineering, and the Union of the German Academies of ... Ebola epidemic today. , In the statement the academies ...
(Date:10/15/2014)... 15, 2014   Neurotechnology , a provider ... availability of the VeriLook Surveillance 3.0 software ... real-time biometric face identification using live video streams ... The new version not only identifies faces in ... objects while they are moving through the video ...
(Date:10/14/2014)... fly genome for the first time, revealing robust immune ... thrives in pathogen-rich dung piles and garbage heaps. , ... Genome Biology , will increase understanding of house fly ... to resist insecticides, which could lead to novel control ... transmit more than 100 human and animal diseases, including ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2
... Jan. 13, 2011 Genomic research could help doctors ... patients, according to a study by Genomic Health Inc. (Nasdaq: ... drug, oxaliplatin, is widely used in colon cancer. It is ... are likely to recur. It is also used in advanced ...
... and Hyde relationship with mercury, but researchers at the ... a discovery that ultimately could help explain the split ... aquatic environments make methylmercury, a more toxic form of ... nature and other types of bacteria can transform methylmercury ...
... Middle schools soon might add fast cafeteria lines to ... according to Penn State researchers. The U.S. Department of ... to Amit Sharma, assistant professor; Martha Conklin, associate professor, ... health sciences, College of Medicine. The project will use ...
Cached Biology News:TGen and Genomic Health Inc. discover genes affecting cancer drug 2Natural dissolved organic matter plays dual role in cycling of mercury 2Quick school cafeteria lines could lead to healthier food choices 2
EDTA, tetrasodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99-101% (as is).Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemicals, Ul...
...
Request Info...
...
Biology Products: